There are 505 papers on neutrophil-to-lymphocyte ratio in aging research: 23 trials and 440 observational studies in people, 13 in animals, 27 reviews. The newest story, Nov 11, 2026: “Kidney scores from body chemistry added to risk prediction”.
Acetylcysteine showed no clear effect on neutrophil-to-lymphocyte ratio in humans (adjuvant to systemic antibiotics) (7.25 ± 3.99 to 5.12 ± 2.23 vs. control group: 10.34 ± 9.17 to 8.5 ± 5.19).
“However, there was no statistically significant difference in the N/L ratio changes between the two groups (N/L ratio change in NAC group: 7.25 ± 3.99 to 5.12 ± 2.23 vs. control group: 10.34 ± 9.17 to 8.5 ± 5.19; P value = 0.84; Table2).”
Human trialadjuvant to systemic antibioticsoral effervescent14 daysn = 56
Baduanjin exercise decreases neutrophil-to-lymphocyte ratio in humans (combined with nutritional support).
“After interventions, grip strength and gait speed of patients in the observation group were higher than those in the control group, while the NLR was lower in the observation group than that in the control group (P < 0.05) (see ).”
Human trialcombined with nutritional support12 weeksn = 74
Baduanjin exercise decreases neutrophil-to-lymphocyte ratio in maintenance hemodialysis patients with sarcopenia (P < 0.05).
“After intervention, patient's grip strength and gait speed were both higher, and the NLR lower in the observation group than those in the control group (P < 0.05).”
Human trialin maintenance hemodialysis patients with sarcopenia12 weeksn = 68
Colchicine decreases neutrophil-to-lymphocyte ratio in humans (chronic coronary artery disease; secondary and exploratory analyses) (Adjusted mean change −0.36 versus −0.08; p=0.033).
“colchicine was associated with a reduction in neutrophil-to-lymphocyte ratio”
Human trialchronic coronary artery disease; secondary and exploratory analyses0.6 mg daily24 weeksn = 111
Preoperative nutrition and exercise is linked with lower neutrophil-to-lymphocyte ratio in humans (undergoing hepatectomy for hepatocellular carcinoma) (p < 0.01).
“The neutrophil-to-lymphocyte ratio was significantly decreased after the intervention compared with before the intervention (p < 0.01).”
Humansundergoing hepatectomy for hepatocellular carcinoma
Empagliflozin showed no clear effect on neutrophil-to-lymphocyte ratio in humans (post-infarction recovery).
“early empagliflozin initiation modulating inflammatory activity in one trial but producing no treatment-specific reduction in NLR during post-infarction recovery in another.”
GLP-1 receptor agonists are linked with lower neutrophil-to-lymphocyte ratio in humans (versus matched nonusers in maintenance hemodialysis) (mean difference -0.67 (95% CI -0.89 to -0.45)).
“GLP-1RA users demonstrated reductions in systemic inflammation, characterized by lower neutrophil-to-lymphocyte ratio (3.97 vs 4.64, with a mean difference of -0.67 [95% CI, -0.89 to -0.45])”
Humansversus matched nonusers in maintenance hemodialysis12 months
Nutrition and exercise intervention decreases neutrophil-to-lymphocyte ratio in frailty patients with gastric cancer undergoing gastrectomy (4.3 ± 0.6 pre-NEI (p = 0.03)).
“The NLR was 4.3 ± 0.6 for pre-NEI and significantly improved by NEI between pre- and post-NEI (p = 0.03).”
Human trialin frailty patients with gastric cancer undergoing gastrectomyn = 15
Neutrophil-to-lymphocyte ratio was not clearly linked with mortality in humans (primary lung cancer, first chemotherapy course, adjusted for confounding factors).
“However, after adjustment for potential confounding factors, no association was found between NLR or PLR and mortality.”
Humansprimary lung cancer, first chemotherapy course, adjusted for confounding factorsn = 926
Neutrophil-to-lymphocyte ratio was not clearly linked with mortality in humans (hospitalized patients with Alzheimer's disease).
“However, the application of neutrophils/lymphocytes, platelets/lymphocytes, and AST/ALT as indicators showed no marked differences between the sarcopenia and non-sarcopenia participants.”
Humanshospitalized patients with Alzheimer's diseasen = 329
Neutrophil-to-lymphocyte ratio is linked with mortality in humans (association of trunk-to-leg lean mass ratio with all-cause mortality) (9.3% (95% CI: 3.3%-40.4%)).
“Neutrophil-to-lymphocyte ratio mediated 9.3% (95% CI: 3.3%-40.4%) of the association of trunk-to-leg lean mass ratio with all-cause mortality.”
Humansassociation of trunk-to-leg lean mass ratio with all-cause mortalitymedian follow-up of 4.18 yearsn = 40,283
Neutrophil-to-lymphocyte ratio is linked with worse cognitive function in hypertensive patients (β = −0.198; risk of cognitive impairment 2.84 times higher with NLR >2.5 (P = 0.003)).
“Multivariate analysis identified age (β = −0.312), elevated systolic blood pressure (SBP) (β = −0.245), NLR (β = −0.198), and SDNN (β = 0.186) as independent predictors of cognitive status.”
Neutrophil-to-lymphocyte ratio is linked with cardiovascular mortality in humans.
“the neutrophil‐to‐lymphocyte ratio was the predominant mediator for CVD mortality.”
HumansAssociation between EAT-Lancet diet adherence and mortality in cardiovascular-kidney-metabolic syndrome stages 0–3Median follow-up of 7.83 yearsn = 9,979
Neutrophil-to-lymphocyte ratio is linked with better mortality risk prediction performance in humans (Added to the prognostic model in patients with heart failure and type 2 diabetes mellitus) (C-index 0.727→0.734; cNRI 15.9%, P=0.021; peak incremental value at 3 months).
“Adding ln-NLR improved model discrimination (C-index: 0.727→0.734) and significantly enhanced reclassification (cNRI=15.9%, P=0.021), with peak incremental value at 3 months.”
HumansAdded to the prognostic model in patients with heart failure and type 2 diabetes mellituslog-transformedn = 469
Neutrophil-to-lymphocyte ratio is linked with better 10-year mortality prediction performance in humans (NLR combined with APACHE III versus APACHE III alone after elective cardiac surgery) (Combined AUC 0.761 versus APACHE III AUC 0.732; P = 0.002).
“Combining NLR with APACHE III improved the AUC to 0.761 (P = 0.002).”
HumansNLR combined with APACHE III versus APACHE III alone after elective cardiac surgery10 yearsn = 4,891
Neutrophil-to-lymphocyte ratio is linked with cardiovascular disease prevalence in humans (Blood Cd: 9.4% mediated (95% CI 3.5%–15.2%); urinary Cd: 5.0% (95% CI 1.9%–8.1%)).
“NLR showed significant exploratory mediating effects (indirect effects), accounting for 9.4% (95% CI: 3.5%-15.2%) of the blood Cd-CVD link”
Humansexploratory cross-sectional mediation of the association between cadmium exposure and cardiovascular diseasemales
Neutrophil-to-lymphocyte ratio was not clearly linked with anti-Müllerian hormone in humans (age-adjusted) (β = -0.012, 95% CI: -0.222 to 0.198, p = 0.912).
“After adjustment for age, neither CRP (β = -0.038, 95% CI: -0.085 to 0.009, p = 0.114) nor NLR (β = -0.012, 95% CI: -0.222 to 0.198, p = 0.912) was independently associated with AMH.”
Neutrophil-to-lymphocyte ratio is associated with mortality in humans (Undergoing non-cardiac surgery; adjusted for potential confounders) (OR 1.039, 95% CI 1.015–1.063).
“Both the GNRI (OR, 0.946, 95% CI, 0.928–0.964, p < 0.001) and NLR (OR, 1.039, 95% CI, 1.015–1.063, p = 0.001) were independently associated with 1-year mortality.”
HumansUndergoing non-cardiac surgery; adjusted for potential confounders1 yearn = 2,480
Neutrophil-to-lymphocyte ratio is associated with mortality in humans (Metabolic syndrome; NHANES; highest versus lowest NLR quartile) (Q4 vs Q1: HR 1.84, 95% CI 1.65–2.04).
“higher NLR levels were associated with increased risks of all-cause mortality (Q4 vs Q1: NHANES HR=1.84, 95% CI 1.65–2.04; Kailuan HR=1.46, 95% CI 1.30–1.63)”
HumansMetabolic syndrome; NHANES; highest versus lowest NLR quartileMedian follow-up of 10 years36.79% womensn = 14,492
Neutrophil-to-lymphocyte ratio is linked with a higher risk of mortality in humans following surgery for proximal femoral fractures (HR = 1.042, 95% CI: 1.032-1.053).
“In multivariable Cox regression, NLR remained independently associated with mortality (HR = 1.042, 95% CI: 1.032-1.053, p < 0.001) after adjusting for age and time to surgery.”
Humansfollowing surgery for proximal femoral fracturesmean follow-up of 33.9 monthsn = 972
Neutrophil-to-lymphocyte ratio predicts frailty in humans (operable non-small-cell lung cancer) (OR 3.13, 95% CI: 1.12-9.09, p = 0.03).
“The log of the neutrophil-to-lymphocyte ratio (logNLR) emerged as the most significant predictor of frailty (OR of 3.13, 95% CI: 1.12-9.09, p = 0.03 for mFI-11”
Neutrophil-to-lymphocyte ratio is linked with a higher risk of frailty in humans (highest 3 deciles (>2.44)) (>2.44).
“Participants in the 3 highest deciles of distribution for NL-ratio (>2.44) were more likely to experience a transition from robust to pre-frail, and to overt frailty status.”
Neutrophil-to-lymphocyte ratio predicts sarcopenia in MHD patients (AUC 0.695).
“The area under ROC curve of NLR for the diagnosis of sarcopenia in MHD patients was 0.695, and when NLR was at the 3.28 cut-off value, its Youden index was 0.369, specificity was 0.750 and sensitivity was 0.619, as shown in.”
Neutrophil-to-lymphocyte ratio raises the risk of sarcopenia in MHD patients.
“However, by multivariate regression analysis, it was indicated that age, hemodialysis duration and NLR were independent factors contributing to the incidence of sarcopenia in MHD patients (see ).”
Neutrophil-to-lymphocyte ratio is linked with a higher risk of sarcopenia in humans (community-dwelling).
“In males, depression status, high-fat mass, higher neutrophils-to-lymphocytes ratio (NLR), lower BMI, lower body weight increased the likelihood of sarcopenia.”
Neutrophil-to-lymphocyte ratio is associated with sarcopenia in humans (cross-sectional analysis; highest vs lowest NLR group after adjustment for covariates) (OR 1.233 [1.002,1.517]).
“neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic immune-inflammation index (SII) were significantly associated with sarcopenia”
Humanscross-sectional analysis; highest vs lowest NLR group after adjustment for covariatesn = 4,224
Journal of investigative medicine : the official publication of the American Federation for Clinical Research·
Neutrophil-to-lymphocyte ratio predicts in-hospital mortality in humans (hospitalized patients) (cut-off ≥ 7.95).
“Both continuous and categorical NLR value (cut-off ≥ 7.95) predicted mortality in bivariate and multivariate prognostic models with a good predictive accuracy.”
Neutrophil-to-lymphocyte ratio predicts in-hospital mortality in humans (Admission NLR >8.5) (AUC 0.793; sensitivity 90%; negative predictive value 99.6%; 9.7 times higher chance of death versus NLR 5.1–8.5).
“the NLR >8.5 predicted in-hospital mortality with an AUC of 0.793”
Neutrophil-to-lymphocyte ratio is associated with 1-year mortality in humans (Proximal femur fractures treated surgically; mutually exclusive adjusted regression models).
“higher NLR and D-dimer levels, lower albumin levels, and a higher composite score were associated with 1-year mortality.”
Neutrophil-to-lymphocyte ratio is linked with a higher risk of lung cancer in current smokers with high inflammatory marker levels (AHR=3.78; 95% CI: 2.65-5.39).
“NLR: AHR=3.78; 95% CI: 2.65-5.39”
Humansin current smokers with high inflammatory marker levelsmales
Neutrophil-to-lymphocyte ratio is associated with lung cancer in humans.
“Sex-stratified analyses revealed stronger associations between Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune Inflammatory Index (SII) and lung cancer in men”
Neutrophil-to-lymphocyte ratio is linked with a higher risk of mild cognitive impairment in humans (OR = 1.33, 95% CI = 1.14-1.55).
“Logistic regression showed that a higher NLR was an independent risk factor for MCI in women [odds ratio (OR) = 1.33; 95% confidence interval (CI) = 1.14-1.55].”
Age is associated with neutrophil-to-lymphocyte ratio in P. troglodytes (cross-sectional comparison) (highest at 20-30 years of age).
“cross-sectional comparisons revealed a significant quadratic relationship between age and NLR, with the highest values during mid-life (20-30 years of age) and the lowest values in younger and older individuals”
Neutrophil-to-lymphocyte ratio is associated with cardiovascular mortality in humans (Metabolic syndrome; NHANES; highest versus lowest NLR quartile) (HR 1.13, 95% CI 1.04–1.22).
“and cardiovascular mortality (NHANES HR=1.13, 95% CI 1.04–1.22; Kailuan HR=1.65, 95% CI 1.40–1.95).”
HumansMetabolic syndrome; NHANES; highest versus lowest NLR quartileMedian follow-up of 10 years36.79% womensn = 14,492
An observational analysis developed scores in 1,723 people and tested them in two cohorts of 9,958 and 5,113 participants.An observational analysis developed scores in 1,723 people and tested them in two cohorts of 9,958 and 5,113 participants.
Who was studiedParticipants in MetaCardis and external validation studies
What changedMetabolite-based kidney scores improved prediction of cardiovascular, kidney and metabolic events and death beyond standard kidney estimates and established risk equations
The catchEffects of interventions changing metabolites on disease or death risks were not measured